About helius medical technologies - HSDT
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
HSDT At a Glance
Solana Co.
642 Newtown Yardley Road
Newtown, Pennsylvania 18940
| Phone | 1-877-564-0008 | Revenue | 520.00K | |
| Industry | Medical Specialties | Net Income | -11,742,000.00 | |
| Sector | Health Technology | Employees | 21 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
HSDT Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 3.493 |
| Price to Book Ratio | 2.36 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.054 |
| Enterprise Value to Sales | 1.424 |
| Total Debt to Enterprise Value | 0.016 |
HSDT Efficiency
| Revenue/Employee | 24,761.905 |
| Income Per Employee | -559,142.857 |
| Receivables Turnover | 0.819 |
| Total Asset Turnover | 0.093 |
HSDT Liquidity
| Current Ratio | 1.58 |
| Quick Ratio | 1.101 |
| Cash Ratio | 0.503 |
HSDT Profitability
| Gross Margin | -23.462 |
| Operating Margin | -2,665.962 |
| Pretax Margin | -2,258.077 |
| Net Margin | -2,258.077 |
| Return on Assets | -209.044 |
| Return on Equity | -688.882 |
| Return on Total Capital | -1,096.359 |
| Return on Invested Capital | -686.466 |
HSDT Capital Structure
| Total Debt to Total Equity | 1.133 |
| Total Debt to Total Capital | 1.12 |
| Total Debt to Total Assets | 0.339 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |